Cargando…
Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial
We investigated the effect of a formula containing two different prebiotics (bifidogenic growth stimulator and galacto-oligosaccharide) and fermented milk products on intestinal microbiota and antibody responses to an influenza vaccine in enterally fed elderly in-patients. Patients were administered...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491666/ https://www.ncbi.nlm.nih.gov/pubmed/26096655 http://dx.doi.org/10.3390/ph8020351 |
_version_ | 1782379679131369472 |
---|---|
author | Nagafuchi, Shinya Yamaji, Taketo Kawashima, Akihiro Saito, Yukiko Takahashi, Takeshi Yamamoto, Takayuki Maruyama, Mitsuo Akatsu, Hiroyasu |
author_facet | Nagafuchi, Shinya Yamaji, Taketo Kawashima, Akihiro Saito, Yukiko Takahashi, Takeshi Yamamoto, Takayuki Maruyama, Mitsuo Akatsu, Hiroyasu |
author_sort | Nagafuchi, Shinya |
collection | PubMed |
description | We investigated the effect of a formula containing two different prebiotics (bifidogenic growth stimulator and galacto-oligosaccharide) and fermented milk products on intestinal microbiota and antibody responses to an influenza vaccine in enterally fed elderly in-patients. Patients were administered either formula containing prebiotics and fermented milk products (group F: n = 12, 79.9 ± 9.5 years old) or standard formula (group C: n = 12, 80.7 ± 10.1 years old) via percutaneous endoscopic gastrostomy during a 14-week intervention period. Subjects were immunized with an influenza vaccine (A/H1N1, A/H3N2, and B) at week 4 of the intervention. Blood biochemical indices, intestinal bacteria populations and antibody titers were analyzed. Bifidobacterium counts increased significantly in group F compared with group C. The enhanced antibody titers against A/H1N1 were maintained in group F for a longer period compared with group C. The titers against A/H3N2 were unchanged between both groups, and those against B were significantly lower in group F than in group C, although few subjects had seroprotective titers against A/H3N2 and B. These results suggest that administration of the formula containing prebiotics and fermented milk products may maintain antibody titers for longer periods through the improvement of intestinal microbiota. |
format | Online Article Text |
id | pubmed-4491666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-44916662015-07-06 Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial Nagafuchi, Shinya Yamaji, Taketo Kawashima, Akihiro Saito, Yukiko Takahashi, Takeshi Yamamoto, Takayuki Maruyama, Mitsuo Akatsu, Hiroyasu Pharmaceuticals (Basel) Article We investigated the effect of a formula containing two different prebiotics (bifidogenic growth stimulator and galacto-oligosaccharide) and fermented milk products on intestinal microbiota and antibody responses to an influenza vaccine in enterally fed elderly in-patients. Patients were administered either formula containing prebiotics and fermented milk products (group F: n = 12, 79.9 ± 9.5 years old) or standard formula (group C: n = 12, 80.7 ± 10.1 years old) via percutaneous endoscopic gastrostomy during a 14-week intervention period. Subjects were immunized with an influenza vaccine (A/H1N1, A/H3N2, and B) at week 4 of the intervention. Blood biochemical indices, intestinal bacteria populations and antibody titers were analyzed. Bifidobacterium counts increased significantly in group F compared with group C. The enhanced antibody titers against A/H1N1 were maintained in group F for a longer period compared with group C. The titers against A/H3N2 were unchanged between both groups, and those against B were significantly lower in group F than in group C, although few subjects had seroprotective titers against A/H3N2 and B. These results suggest that administration of the formula containing prebiotics and fermented milk products may maintain antibody titers for longer periods through the improvement of intestinal microbiota. MDPI 2015-06-18 /pmc/articles/PMC4491666/ /pubmed/26096655 http://dx.doi.org/10.3390/ph8020351 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nagafuchi, Shinya Yamaji, Taketo Kawashima, Akihiro Saito, Yukiko Takahashi, Takeshi Yamamoto, Takayuki Maruyama, Mitsuo Akatsu, Hiroyasu Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title | Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title_full | Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title_fullStr | Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title_full_unstemmed | Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title_short | Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial |
title_sort | effects of a formula containing two types of prebiotics, bifidogenic growth stimulator and galacto-oligosaccharide, and fermented milk products on intestinal microbiota and antibody response to influenza vaccine in elderly patients: a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491666/ https://www.ncbi.nlm.nih.gov/pubmed/26096655 http://dx.doi.org/10.3390/ph8020351 |
work_keys_str_mv | AT nagafuchishinya effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT yamajitaketo effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT kawashimaakihiro effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT saitoyukiko effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT takahashitakeshi effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT yamamototakayuki effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT maruyamamitsuo effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial AT akatsuhiroyasu effectsofaformulacontainingtwotypesofprebioticsbifidogenicgrowthstimulatorandgalactooligosaccharideandfermentedmilkproductsonintestinalmicrobiotaandantibodyresponsetoinfluenzavaccineinelderlypatientsarandomizedcontrolledtrial |